Morphologic Abnormalities of Neoplasms

{
  "description" : "HL7 Implementation Guide for CDA© Release 2: Reporting to Public Health \r\nCancer Registries from Ambulatory Healthcare Providers, Release 1 \r\n(US Realm) Draft Standard for Trial Use.\r\nContains codes descending \r\nfrom the following SNOMED CT® concepts: Malignant neoplasm of primary, \r\nsecondary, or uncertain origin (morphologic abnormality) [367651003], \r\nNervous system tumor morphology (morphologic abnormality) [253061008], \r\nIntratubular malignant germ cells (morphologic abnormality) \r\n[128902002], In situ melanocytic morphology (morphologic abnormality) \r\n[253035009], In situ neoplasm (morphologic abnormality) [127569003], \r\nCarcinoma in situ - category (morphologic abnormality) [399919001], \r\nSquamous intraepithelial neoplasia - category (morphologic abnormality) \r\n[399962000], In situ adenomatous neoplasm - category (morphologic \r\nabnormality) [399983006].",
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://snomed.info/sct",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 1034
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ],
      "version" : "http://snomed.info/sct/731000124108/version/20200901"
    } ]
  },
  "meta" : {
    "source" : "https://phinvads.cdc.gov/vads/ViewValueSet.action?oid=2.16.840.1.114222.4.11.7256"
  },
  "name" : "PHVS_MorphologicAbnormalitiesOfNeoplasms",
  "resourceType" : "ValueSet",
  "title" : "Morphologic Abnormalities of Neoplasms",
  "extension" : [ {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "draft",
  "id" : "2.16.840.1.114222.4.11.7256",
  "url" : "http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7256",
  "version" : "3"
}